Eliquis Does Not Cause Burning Sensation with Touch or Pressure
Burning sensation triggered by light touch or pressure is not a recognized side effect of apixaban (Eliquis). This symptom is not listed in the FDA-approved prescribing information or reported in major clinical trials.
Known Side Effects of Eliquis
According to the FDA drug label, the documented adverse reactions to apixaban include 1:
- Bleeding complications (the primary concern with any anticoagulant)
- Hypersensitivity reactions including:
- Skin rash
- Drug hypersensitivity
- Anaphylactic reactions with allergic edema
- Syncope (fainting)
These reactions occurred in less than 1% of patients in clinical trials 1.
Dermatologic Reactions: What Has Been Reported
While burning sensations are not documented, there are rare case reports of skin-related reactions to apixaban:
Documented skin reactions include:
- Leukocytoclastic vasculitis (LCV) - a small vessel inflammation causing palpable purpura, petechiae, and painful rash 2, 3, 4
- Pruritic (itchy) erythematous rashes 5
- Urticarial rash associated with anaphylaxis 6
These dermatologic reactions typically present as visible rashes with purpura, petechiae, or erythema - not isolated burning sensations without visible skin changes 2, 3, 5.
Clinical Interpretation
If a patient reports burning sensation with tactile touch or pressure while taking Eliquis:
This is likely unrelated to apixaban - consider alternative diagnoses such as:
- Peripheral neuropathy
- Allodynia from other causes
- Neurological conditions
- Other medication effects
Examine the skin carefully - if there is an accompanying rash, petechiae, or purpura, consider drug-induced vasculitis and obtain dermatology consultation with possible skin biopsy 3, 4
Do not discontinue anticoagulation without careful assessment of thrombotic risk versus the likelihood that apixaban is causing the symptom
Important Caveat
The major clinical concern with apixaban remains bleeding risk, not sensory symptoms 7, 1. Patients should be counseled about signs of bleeding (unusual bruising, prolonged bleeding, blood in urine/stool, severe headache) rather than burning sensations, which are not part of the known adverse effect profile.